ChiCTR2000030222 版本V1.1 版本创建时间2020/02/28 17:49:51 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000030222 

最近更新日期:

Date of Last Refreshed on:

2020-02-28 17:48:45 

注册时间:

Date of Registration:

2020-02-25 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

撤消 新型冠状病毒肺炎(COVID-19)疫情对老年人健康的影响

Public title:

Cancelled due to lack of participants Study for the Impact of Novel Coronavirus Pneumonia (COVID-19) to the Health of the elderly People

注册题目简写:

English Acronym:

研究课题的正式科学名称:

新型冠状病毒肺炎(COVID-19)疫情对老年人的影响

Scientific title:

Study for the Impact of Novel Coronavirus Pneumonia (COVID-19) to the Health of the elderly People

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

孙文静 

研究负责人:

湛斌 

Applicant:

Wenjing Sun 

Study leader:

Bin Zhan 

申请注册联系人电话:

Applicant telephone:

+86 13594359858

研究负责人电话:

Study leader's telephone:

+86 13678494357

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

fountaincs@163.com

研究负责人电子邮件:

Study leader's E-mail:

406302524@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市九龙坡区铁路新村16号

研究负责人通讯地址:

重庆市九龙坡区铁路新村16号

Applicant address:

16 Railway New Village, Jiulongpo Districts, Chongqing, China

Study leader's address:

16 Railway New Village, Jiulongpo Districts, Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆市第十三人民医院

Applicant's institution:

The Thirteenth People's Hospital of Chongqing

研究负责人所在单位:

重庆市第十三人民医院

Affiliation of the Leader:

The Thirteenth People's Hospital of Chongqing

是否获伦理委员会批准:

否/No

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆市第十三人民医院

Primary sponsor:

The Thirteenth People's Hospital of Chongqing

研究实施负责(组长)单位地址:

重庆市九龙坡区铁路新村16号

Primary sponsor's address:

16 Railway New Village, Jiulongpo Districts, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆市

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆市第十三人民医院

具体地址:

重庆市九龙坡区铁路新村16号

Institution
hospital:

The Thirteenth People's Hospital of Chongqing

Address:

16 Railway New Village, Jiulongpo Districts

经费或物资来源:

自筹

Source(s) of funding:

self-raised

Target disease:

Geriatrics; Novel Coronavirus Pneumonia (COVID-19)

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

了解新型冠状病毒肺炎疫情对老年人群健康状况、心理健康等的影响,为建立疫情期间老年人健康评估及干预策略提供依据。  

Objectives of Study:

To understand the impact of the outbreak of NCP on the health status of the elderly population, so as to provide a basis for the establishment of health assessment and intervention strategies for the elderly during the outbreak.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

年龄≥60岁以上者,愿意参加此项调查研究者。

Inclusion criteria

subjects who are over 60 years old, and willing to participate in the investigation.

排除标准:

1. 无法完成问卷调查的患者;
2. 非自愿参加调查的患者及健康人群。

Exclusion criteria:

1. Patients who are unable to complete the questionnaire;
2. Patients and healthy people who are not willing to participate in the survey.

研究实施时间:

Study execute time:

From 2020-02-21 00:00:00 To 2021-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-02-21 00:00:00 To 2021-02-28 00:00:00  

干预措施:

Interventions:

组别:

老年人群

样本量:

658

Group:

the elderly population

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆市 

市(区县):

 

Country:

China 

Province:

Chongqing 

City:

 

单位(医院):

重庆市第十三人民医院 

单位级别:

二级甲等 

Institution
hospital:

The Thirteenth People's Hospital of Chongqing

Level of the institution:

Secondary A Hospital

测量指标:

Outcomes:

指标中文名:

健康状态

指标类型:

主要指标

Outcome:

health status

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心理健康状态

指标类型:

主要指标

Outcome:

Mental health status

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

非随机对照试验

Randomization Procedure (please state who generates the random number sequence and by what method):

non-randomized control trial

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

原始数据将以文章发表的方式共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Raw data will be shared in the form of articles published

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集通过问卷调查进行;数据管理由易企秀平台管理。电子表格数据库有多个备份保存于不同磁盘或记录介质上,妥善保存,防止破坏。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data were collected through questionnaires. The data management is unified on the Wenjuanxing platform. Multiple backups of the spreadsheet database are kept on different disks or recording media.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-02-26 00:33:39